Research & Case Studies

Breast thermography has been researched for over 30 years and over 800 peer reviewed breast thermography studies exist in the index-medicus.  Some studies have shown that when thermography is added to a woman's regular breast health checkup, a 61% increased survival rate has been realized.  And when used as a part of a mulitmodal approach (clinical examination + mammography + thermography) 95% of early stage cancers will be detected.  Thermography, with its non-radiation, non-contact and low-cost basis has been clearly demonstrated to be a valuable and safe early risk marker of breast pathology.  It has proven to be an excellent case management tool for the ongoing monitoring and treatment of breast disease when used under carefully controlled clinical protocols.

For updated research, studies and information, visit:

www.acct-blog.com

Active Cancer Cells Double Every 90 days

90 days          2 cells

1 year             16 cells

2 years           256 cells 

3 years           4,896 cells

4 years           65,536 cells

5 years           1,048,576 cells**

6 years           16,777,216 cells

7 years           268,435,456 cells

8 years           4,294,967,296 cells***

 

**still undetectable by Mammography

***doubled 32 times, now detectable by Mammography

 

40 Doublings (Approximately 10 years) considered lethal.

Source: Oncology News (Cancer Journal)

Screening thermography has the opportunity to detect changes at any stage in the development from the first year through to when a tumor is dense enough to be seen with mammography. This early detection of

change can lead to earlier diagnosis and better treatment options as well as the opportunity for patients and their healthcare practitioners to intervene at an early stage with preventative treatment.

© 2019 by Mobile Thermographic Imaging. All rights reserved.

Disclaimer: Breast thermography is not a replacement or alternative for mammography or any other form of breast imaging. Breast thermography is meant to be used in addition to mammography and other tests. Breast thermography and mammography are complementary procedures, one does not replace the other. All thermography reports are meant to identify thermal emissions that suggest potential risk markers only and do not in any way suggest diagnosis and/or treatment. No breast screening is 100% accurate. The information provided in or through this website is not intended to be a substitute for professional medical advice, diagnosis or treatment provided by your own Medical Provider. Mobile Thermographic Imaging has no liability to any person or entity for any adverse consequence alleged to have happened directly or indirectly as a consequence of this material. The information provided in or through this website is for educational and informational purposes only. Telethermography systems are FDA regulated as a medical device under 21 CFR 884.2980. Telethermographic systems are intended as an adjunctive diagnostic screening

  • b-facebook